Dark Spot
Study Number: C25-D149
Study Location:
Dallas Research Center: 1801 N. Glenville Dr., Suite 250 Richardson, Texas 75081
Compensation: Up to $650.00
Gender:
Male and Female
Age:
18-65 years old
Skin Type:
Fitz I-VI
Study Description:
This clinical trial is designed to evaluate the effectiveness of the Sponsor’s facial products over a 12-week treatment period, followed by an 8-week regression phase. The study includes male and female participants presenting with at least one facial dark spot measuring ≥3 mm in diameter with moderate intensity, as well as moderate overall facial hyperpigmentation.
Study Requirements:
Must:
- Have at least 1 dark spot 3mm in size on global face
Cannot:
- Cannot have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as multiple sclerosis, Crohn’s disease, HIV, or rheumatoid arthritis).
Visit 1 Instructions
- Avoid the use of any topical products to the face at least 3 days prior to first visit.
- Bring a valid ID or passport.
- If you are not able to make your appointment, please contact us ASAP by calling us at 833-530-7596.
Complete the prescreening survey below:
All information you provide will be kept confidential, you may be contacted by telephone or text, and your information may be added to a database.